Effects of Different Routes and Forms of Vitamin D Administration on Mesenteric Lymph Node CD4+ T Cell Polarization and Intestinal Injury in Obese Mice Complicated with Polymicrobial Sepsis
暂无分享,去创建一个
Ming-Hsun Wu | Ming-Tsan Lin | C. Yeh | S. Yeh | Jin-Ming Wu | Po-Chu Lee | Po-Da Chen | Po-Jen Yang | Kuen-Yuan Chen | Po-Da Chen
[1] A. Slominski,et al. Molecular and structural basis of interactions of vitamin D3 hydroxyderivatives with aryl hydrocarbon receptor (AhR): An integrated experimental and computational study. , 2022, International journal of biological macromolecules.
[2] Godfraind Catherine,et al. AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms , 2022, Gut microbes.
[3] Ming-Tsan Lin,et al. Intravenous calcitriol administration modulates mesenteric lymph node CD4+ T-cell polarization and attenuates intestinal inflammation in obese mice complicated with polymicrobial sepsis. , 2021, JPEN - Journal of Parenteral and Enteral Nutrition.
[4] A. Rosenwald,et al. Mesenteric Lymph Node Transplantation in Mice to Study Immune Responses of the Gastrointestinal Tract , 2021, Frontiers in Immunology.
[5] Kuen-Yuan Chen,et al. Intravenous calcitriol administration regulates the renin-angiotensin system and attenuates acute lung injury in obese mice complicated with polymicrobial sepsis. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[6] M. Haussler,et al. Introduction: Special Issue on Vitamin D Dedicated to the Memory of Anthony W Norman , 2020, JBMR Plus.
[7] M. Holick,et al. Immunologic Effects of Vitamin D on Human Health and Disease , 2020, Nutrients.
[8] M. Henríquez,et al. Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency , 2020, Nutrients.
[9] S. Karras,et al. Vitamin D and intestinal homeostasis: Barrier, microbiota, and immune modulation , 2020, The Journal of Steroid Biochemistry and Molecular Biology.
[10] Jun Yu,et al. Cathelicidin preserves intestinal barrier function in polymicrobial sepsis , 2020, Critical care.
[11] J. Windsor,et al. Gastrointestinal Dysfunction in Critical Illness: A Review of Scoring Tools. , 2020, JPEN. Journal of parenteral and enteral nutrition.
[12] Xiaojie Gan,et al. Vitamin D alleviates acute graft-versus-host disease through promoting the generation of Foxp3+ T cells. , 2019, Annals of translational medicine.
[13] M. Kamboh,et al. Vitamin D as a Principal Factor in Mediating Rheumatoid Arthritis-Derived Immune Response , 2019, BioMed research international.
[14] P. Pelosi,et al. Obesity in the critically ill: a narrative review , 2019, Intensive Care Medicine.
[15] L. Rejnmark,et al. Managing vitamin D deficiency in inflammatory bowel disease , 2019, Frontline Gastroenterology.
[16] C. Tamone,et al. Vitamin D: Nutrient, Hormone, and Immunomodulator , 2018, Nutrients.
[17] Yousheng Li,et al. Vitamin D Improves Intestinal Barrier Function in Cirrhosis Rats by Upregulating Heme Oxygenase-1 Expression , 2018, Biomolecules & therapeutics.
[18] Hua Yang,et al. 6-Formylindolo(3,2-b)carbazole induced aryl hydrocarbon receptor activation prevents intestinal barrier dysfunction through regulation of claudin-2 expression. , 2018, Chemico-biological interactions.
[19] R. Kumar,et al. The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease. , 2017, Endocrinology and metabolism clinics of North America.
[20] D. Heyland,et al. Vitamin D supplementation in the critically ill: A systematic review and meta-analysis. , 2017, Clinical nutrition.
[21] D. Tsikas. Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges. , 2017, Analytical biochemistry.
[22] Seong-Min Lee,et al. The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights. , 2017, The Journal of clinical investigation.
[23] A. Cavani,et al. IL‐17 and IL‐22 in immunity: Driving protection and pathology , 2017, European journal of immunology.
[24] S. Bhoi,et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with post traumatic sepsis. , 2016, Cytokine.
[25] D. Aretha,et al. The Role of Obesity in Sepsis Outcome among Critically Ill Patients: A Retrospective Cohort Analysis , 2016, BioMed research international.
[26] C. Coopersmith,et al. Mechanisms of Intestinal Barrier Dysfunction in Sepsis , 2016, Shock.
[27] G. Martin,et al. High dose vitamin D administration in ventilated intensive care unit patients: A pilot double blind randomized controlled trial , 2016, Journal of clinical & translational endocrinology.
[28] A. Ananthakrishnan. Editorial: Vitamin D and IBD: Can We Get Over the “Causation” Hump? , 2016, The American Journal of Gastroenterology.
[29] I. Nagaoka,et al. Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice. , 2016, International immunology.
[30] Shery Jacob,et al. A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.
[31] Christopher W Seymour,et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[32] L. Maggio-Price,et al. Protective links between vitamin D, inflammatory bowel disease and colon cancer. , 2016, World journal of gastroenterology.
[33] C. Camargo,et al. Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial , 2015, Critical care medicine.
[34] S. Upala,et al. Significant association between vitamin D deficiency and sepsis: a systematic review and meta-analysis , 2015, BMC Anesthesiology.
[35] M. Cantorna,et al. Vitamin D and 1,25(OH)2D Regulation of T cells , 2015, Nutrients.
[36] H. D. de Geus,et al. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis , 2014, Critical Care.
[37] V. Badovinac,et al. Impact of sepsis on CD4 T cell immunity , 2014, Journal of leukocyte biology.
[38] D. Leaf,et al. Randomized controlled trial of calcitriol in severe sepsis. , 2014, American journal of respiratory and critical care medicine.
[39] W. Grady,et al. Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer. , 2014, Cancer research.
[40] D. Deb,et al. 1,25-Dihydroxyvitamin D Promotes Negative Feedback Regulation of TLR Signaling via Targeting MicroRNA-155–SOCS1 in Macrophages , 2013, The Journal of Immunology.
[41] S. Peltier,et al. Vitamin D metabolism, functions and needs: from science to health claims , 2013, European Journal of Nutrition.
[42] Jun Sun,et al. Vitamin D, vitamin D receptor and tissue barriers , 2013, Tissue barriers.
[43] Qiurong Li,et al. Lipopolysaccharide-Induced Bacterial Translocation Is Intestine Site-Specific and Associates with Intestinal Mucosal Inflammation , 2012, Inflammation.
[44] P. Webb,et al. Occludin is required for apoptosis when claudin–claudin interactions are disrupted , 2012, Cell Death and Disease.
[45] C. Garlanda,et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch , 2011, Nature Immunology.
[46] M. Jenkins,et al. Origins of CD4+ effector and central memory T cells , 2011, Nature Immunology.
[47] T. Pieber,et al. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study , 2011, Critical care.
[48] D. Ye,et al. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention , 2011, Molecular and Cellular Biochemistry.
[49] David A Hildeman,et al. T CELLS ARE POTENT EARLY MEDIATORS OF THE HOST RESPONSE TO SEPSIS , 2010, Shock.
[50] Jerrold R. Turner,et al. Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.
[51] H. Mukhtar,et al. Aryl hydrocarbon receptor is an ozone sensor in human skin. , 2009, The Journal of investigative dermatology.
[52] S. Amini,et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[53] Jie-shou Li,et al. Disruption of tight junctions during polymicrobial sepsis in vivo , 2009, The Journal of pathology.
[54] V. Kuchroo,et al. Induction and effector functions of TH17 cells , 2008, Nature.
[55] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[56] J. Turner,et al. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. , 2006, The American journal of pathology.
[57] M. Falagas,et al. Obesity and infection. , 2006, The Lancet. Infectious diseases.
[58] John H. White,et al. Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression1 , 2004, The Journal of Immunology.
[59] D. Taupin,et al. Trefoil factors: initiators of mucosal healing , 2003, Nature Reviews Molecular Cell Biology.
[60] M. Uskoković,et al. A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .
[61] M. Cantorna,et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. , 2000, The Journal of nutrition.
[62] C. Probert,et al. Mucins and inflammatory bowel disease , 2000, Postgraduate medical journal.
[63] I. Chaudry,et al. Immune suppression in polymicrobial sepsis: differential regulation of Th1 and Th2 responses by p38 MAPK. , 2000, The Journal of surgical research.
[64] J. Macfie,et al. Microbiology of bacterial translocation in humans , 1998, Gut.
[65] J. Dipiro. Cytokine Networks with Infection: Mycobacterial Infections, Leishmaniasis, Human Immunodeficiency Virus Infection, and Sepsis , 1997, Pharmacotherapy.
[66] J. Hassett,et al. The Gut Origin Septic States in Blunt Multiple Trauma (ISS = 40) in the ICU , 1987, Annals of surgery.
[67] R. Berg,et al. Bacterial translocation from the gastrointestinal tract of athymic (nu/nu) mice , 1980, Infection and immunity.
[68] C. Elmets,et al. The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers. , 2020, Advances in experimental medicine and biology.
[69] M. Fernández,et al. Impact of Obesity and Metabolic Syndrome on Immunity. , 2016, Advances in nutrition.
[70] J. Macfie. Current status of bacterial translocation as a cause of surgical sepsis. , 2004, British medical bulletin.
[71] M. Uskoković,et al. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. , 2002, Diabetes.
[72] N. Webster,et al. T helper cell subset ratios in patients with severe sepsis , 1999, Intensive Care Medicine.